Skip to main content
SpringerLink
Log in

Epidemiology

  • Chapter
  • First Online:
Bronchiectasis

  • 1042 Accesses

Abstract

The real incidence and prevalence of bronchiectasis in general populations is not known and is difficult to estimate because a computed tomography scan is necessary for its diagnosis. The incidence of cystic fibrosis is 1:2000–3500 live births in northern Europe and North America. Epidemiological data show an increase in the incidence and prevalence of bronchiectasis, as well as an increase in hospital admissions and mortality in the last two decades, even in patients with a higher socioeconomic status. The prevalence and incidence increase with age in both men and women. The clinical heterogeneity of bronchiectasis and the great number of etiologies, some of which are uncommon, justify the establishment of international registries to improve our knowledge of the epidemiology of this condition. Bronchiectasis is associated with significant morbidity and increased mortality, and respiratory problems are the most common cause of death. The presence of bronchiectasis can have implications in the prognosis of other diseases. The incremental direct costs of bronchiectasis are significant. Indirect cost data (e.g., due to absenteeism from work) are lacking, clearly underestimating the economic burden from a societal perspective.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Vendrell M, de Gracia J, Olveira C, Martínez MA, Girón R, Máiz L, et al. Diagnosis and treatment of bronchiectasis. Spanish society of pneumology and thoracic surgery. Arch Bronconeumol. 2008;44:629–40.

    Article  PubMed  Google Scholar 

  2. Dupuis A, Hamilton D, Cole DE, Corey M. Cystic fibrosis birth rates in Canada: a decreasing trend since the onset of genetic testing. J Pediatr. 2005;147:312–5.

    Article  PubMed  Google Scholar 

  3. Yen E, Quinton H, Borowitz D. Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J Pediatr. 2013;162:530–5.

    Article  PubMed  Google Scholar 

  4. CF Trust. Cystic fibrosis trust annual data report 2011; 2013.

    Google Scholar 

  5. Cystic Fibrosis Foundation. Cystic fibrosis foundation patient registry 2013 annual data report, Bethesda (MD); 2014.

    Google Scholar 

  6. McKone EF, Goss CH, Aitken ML. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest. 2006;130:1441–7.

    Article  PubMed  Google Scholar 

  7. de Gracia J, Mata F, Alvarez A, Casals T, Gartner S, Vendrell M, et al. Genotype-phenotype correlation for pulmonary function incystic fibrosis. Thorax. 2005;60:558–63.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005;12:205–9.

    Article  Google Scholar 

  9. Ringshausen FC, de Roux A, Diel R, Hohmann D, Welte T, Rademacher J. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J. 2015;46:1805–7.

    Article  CAS  PubMed  Google Scholar 

  10. Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots R. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest. 2012;142:432–9.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ringshausen FC, de Roux A, Pletz MW, Hämäläinen N, Welte T, Rademacher J. Bronchiectasis-associated hospitalizations in Germany, 2005–2011: a population-based study of disease burden and trends. PLoS One. 2013;8:e71109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Seitz AE, Olivier KN, Steiner CA, Montes de Oca R, Holland SM, Prevots DR. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993–2006. Chest. 2010;138:944–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Saynajakangas O, Keistinen T, Tuuponen T, Kivela SL. Bronchiectasis in Finland: trends in hospital treatment. Respir Med. 1997;91:395–8.

    Article  CAS  PubMed  Google Scholar 

  14. Quint JK, Millett ER, Joshi M, Navaratnam V, Thomas SL, Hurst JR, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J. 2016;47:186–93.

    Article  PubMed  Google Scholar 

  15. Monteagudo M, Rodríguez-Blanco T, Barrecheguren M, Simonet P, Miravitlles M. Prevalence and incidence of bronchiectasis in Catalonia, Spain: a population-based study. Respir Med. 2016;121:26–31.

    Article  PubMed  Google Scholar 

  16. Wyn-Williams N. Bronchiectasis: a study centred on Bedford and its environs. BMJ. 1953;1:1194–9.

    Article  Google Scholar 

  17. Martínez-García MA, Vendrell M, Girón R, Máiz-Carro L, de la Rosa CD, de Gracia J, Olveira C. The multiple faces of non-cystic fibrosis bronchiectasis: a cluster analysis approach. Ann Am Thorac Soc. 2016;13:1468–75.

    Article  PubMed  Google Scholar 

  18. Kwak HJ, Moon JY, Choi YW, Kim TH, Sohn JW, Yoon HJ, et al. High prevalence of bronchiectasis in adults: analysis of CT findings in a health screening program. Tohoku J Exp Med. 2010;222:237–42.

    Article  PubMed  Google Scholar 

  19. De Gracia J, Vendrell M, Álvarez A, Pallisa E, Rodrigo MJ, De la Rosa D, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol. 2004;4:745–53.

    Article  PubMed  Google Scholar 

  20. Chalmers JD, Aliberti S, Polverino E, Vendrell M, Crichton M, Loebinger M, et al. The EMBARC European bronchiectasis registry: protocol for an international observational study. ERJ Open Res. 2016;2:00081–2015.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Keistinen T, Säynäjäkangas O, Tuuponen T, Kivelä SL. Bronchiectasis: an orphan disease with a poorly-understood prognosis. Eur Respir J. 1997;10:2784–7.

    Article  CAS  PubMed  Google Scholar 

  22. Perry KMA, King DS. Bronchiectasis: a study of prognosis based on a follow-up of 400 patients. Am Rev. Tuberc. 1940;41:531–48.

    Google Scholar 

  23. Konietzko NF, Carton RW, Leroy EP. CaU.S.es of death in patients with bronchiectasis. Am Rev. Respir Dis. 1969;100:852–8.

    CAS  PubMed  Google Scholar 

  24. Ellis DA, Thornley PE, Wightman AJ, Walker M, Chalmers J, Crofton JW. Present outlook in bronchiectasis: clinical and social study and review of factors influencing prognosis. Thorax. 1981;36:659–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Dupont M, Gacouin A, Lena H, Lavoué S, Brinchault G, Delaval P, Thomas R. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest. 2004;125:1815–20.

    Article  PubMed  Google Scholar 

  26. Roberts HJ, Hubbard R. Trends in bronchiectasis mortality in England and Wales. Respir Med. 2010;104:981–5.

    Article  PubMed  Google Scholar 

  27. Finklea JD, Khan G, Thomas S, Song J, Myers D, Arroliga AC. Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis. Respir Med. 2010;104:816–21.

    Article  PubMed  Google Scholar 

  28. Roberts ME, Lowndes L, Milne DG, Wong CA. Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis. Intern Med J. 2012;42:e129–36.

    Article  CAS  PubMed  Google Scholar 

  29. Goeminne PC, Nawrot TS, Ruttens D, Seys S, Dupont LJ. Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients. Respir Res. 2012;13:21.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Onen ZP, Gulbay BE, Sen E, Yildiz OA, Saryal S, Acican T, Karabiyikoglu G. Analysis of the factors related to mortality in patients with bronchiectasis. Respir Med. 2007;101:1390–7.

    Article  PubMed  Google Scholar 

  31. Loebinger MR, Wells AU, Hansell DM, Chinyanganya N, Devaraj A, Meister M, Wilson R. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J. 2009;34:843–9.

    Article  CAS  PubMed  Google Scholar 

  32. Goeminne PC, Nawrot TS, Ruttens D, Seys S, Dupont LJ. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis. Respir Med. 2014;108:287–96.

    Article  CAS  PubMed  Google Scholar 

  33. Martínez-García MÁ, de Gracia J, Vendrell Relat M, Girón RM, Máiz Carro L, de la Rosa CD, Olveira C. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J. 2014;43:1357–67.

    Article  PubMed  Google Scholar 

  34. Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189:576–85.

    Article  PubMed  PubMed Central  Google Scholar 

  35. McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016;4:969–79.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Iwagami M, Mansfield K, Quint J, Nitsch D, Tomlinson L. Diagnosis of acute kidney injury and its association with in-hospital mortality in patients with infective exacerbations of bronchiectasis: cohort study from a UK nationwide database. BMC Pulm Med. 2016;16:14. https://doi.org/10.1186/s12890-016-0177-5.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Swinson DR, Symmons D, Suresh U, Jones M, Booth J. Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol. 1997;36:689–91.

    Article  CAS  PubMed  Google Scholar 

  38. Puéchal X, Génin E, Bienvenu T, Le Jeunne C, Dusser DJ. Poor survival in rheumatoid arthritis associated with bronchiectasis: a family-based cohort study. PLoS One. 2014;9(10):e110066. https://doi.org/10.1371/journal.pone.0110066.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Martínez-García MA, de la Rosa CD, Soler-Cataluña JJ, Donat-Sanz Y, Serra PC, Lerma MA, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:823–31.

    Article  PubMed  Google Scholar 

  40. Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest. 2007;131:524–32.

    Article  PubMed  Google Scholar 

  41. Dury S, Colosio C, Etienne I, Anglicheau D, Merieau E, Caillard S, et al. Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study. BMC Pulm Med. 2015;15:141.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hayes D Jr, Kopp BT, Tobias JD, Woodley FW, Mansour HM, Tumin D, Kirkby SE. Survival in patients with advanced non-cystic fibrosis bronchiectasis versus cystic fibrosis on the waitlist for lung transplantation. Lung. 2015;193:933–8.

    Article  CAS  PubMed  Google Scholar 

  43. de la Rosa D, Martínez-Garcia MA, Olveira C, Girón R, Máiz L, Prados C. Annual direct medical costs of bronchiectasis treatment: impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence. Chron Respir Dis. 2016;12:361–71.

    Article  Google Scholar 

  44. Sánchez-Muñoz G, Lopez de Andres A, Jimenez-Garcia R, et al. Time trends in hospital admissions for bronchiectasis: analysis of the Spanish national hospital discharge data (2004 to 2013). PLoS One. 2016;11:e0162282.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Joish VN, Spilsbury-Cantalupo M, Operschall E, Luong B, Boklage S. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective. Appl Health Econ Health Policy. 2013;11:299–304.

    Article  PubMed  Google Scholar 

  46. Blanchette C, Noone J, Stone G, et al. Healthcare cost and utilization before and after diagnosis of Pseudomonas aeruginosa among patients with non-cystic fibrosis bronchiectasis in the US. Pneumologie. 2016;70:A61.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bronchiectasis Group, IDIBGI, Dr.Trueta University Hospital, UdG, Girona, Spain

    Montserrat Vendrell

  2. Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Faculty of Medicine Novi Sad, University of Novi Sad, Novi Sad, Serbia

    Dušanka Obradović

  3. Institut für Epidemiologie, Christian-Albrechts-Universität zu Kiel, c/o LungenClinic Grosshansdorf Wöhrendamm 80, D-22927, Großhansdor, Germany

    Roland Diel

  4. Department of Pneumology, Vall d’Hebron University Hospital, Universitat Autònoma Barcelona, Bellaterra, Barcelona, Spain

    Javier de Gracia

Authors
  1. Montserrat Vendrell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dušanka Obradović
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roland Diel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Javier de Gracia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Montserrat Vendrell .

Editor information

Editors and Affiliations

  1. College of Medicine, University of Dundee , Dundee, United Kingdom

    James Chalmers

  2. Hospital Vall D’Hebron, Vall D’Hebron Research Institute (VHIR) Respiratory Disease Department, Barcelona, Spain

    Eva Polverino

  3. Department of Pathophysiology and Transplantation, University of Milan Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

    Stefano Aliberti

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vendrell, M., Obradović, D., Diel, R., de Gracia, J. (2018). Epidemiology. In: Chalmers, J., Polverino, E., Aliberti, S. (eds) Bronchiectasis. Springer, Cham. https://doi.org/10.1007/978-3-319-61452-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61452-6_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61451-9

  • Online ISBN: 978-3-319-61452-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation